Skip to main content
. 2021 Jan 5;28(3):653–663. doi: 10.1093/jamia/ocaa296

Table 2.

Summary of study characteristics

Characteristic Variable Results
Study Design Retrospective cohort 66 (82.5)5,28–92
Prospective cohort 5 (6.3)93–97
Case-control 3 (3.8)98–100
Qualitative 3 (3.8)12,101,102
Retrospective + prospective cohort 3 (3.8)103–105
Locationa United States 55 (68.8)5,28,29,31,32,34,36,40–44,47–50,52,54–60,62,63,65–70,73–80,82,83,85,90–93,95,97–100,102,104,105
United Kingdom 7 (8.8)39,53,55,61,63,67,77
Taiwan 5 (6.3)38,39,45,67,88
Canada 4 (5)12,33,81,87
China 4 (5)37,39,71,103
Australia 3 (3.8)86,94,96
Germany 2 (2.5)51,101
India 2 (2.5)64,89
Switzerland 2 (2.5)35,72
South Korea 1 (1.3)30
Saudi Arabia 1 (1.3)46
Spain 1 (1.3)84
France 1 (1.3)76
Portugal 1 (1.3)75
Year 2019 23 (28.8)12,42,43,60,64,65,67,68,70,72,79,82,83,92,95–99,101–103,105
2018 18 (22.5)30,36,39,41,46,61,63,66,69,71,74,78,81,88,89,91,94,104
2017 15 (18.8)5,29,31,44,51–53,57,58,75,77,80,85,87,100
2016 12 (15)28,32,37,40,47,49,50,62,73,84,86,93
2015 12 (15)33–35,38,45,48,54–56,59,76,90
Machine learning methodsa Neural networks 34 (42.5)28–33,35,39,41,43,45,47–51,54,60,66,68,70,72,76,79–84,89,94,96,99,100
Random forests 32 (40)30,35–38,40,42–44,49–51,54,57,63–66,71,76,79,83,88,90,91,94,95,97,98,103–105
Regressionb 27 (33.8)30,32,35,39–41,43,47,48,50,54,56,61,62,65,70,76,79,83,84,87,88,90–92,94,95
Support vector machines 24 (30)32,34,35,37–39,44,46–48,50,51,55–57,59,61,62,66,75,79,94,98,103
Boosting 17 (21.3)32,47,49,50,52,53,65–67,69,76,78,90,91,94,98,103
Decision trees 15 (18.8)32,35,38–40,47,48,50,52,53,56,62,76,78,88
Penalized regressionc 13 (16.3)5,35,37,44,55,57,65,66,91,95,98,100,103
Bayesian 13 (16.3)5,35,37,39,44,57,62,66,76,79,86,93,98
Topic modeling 9 (11.3)55,57,59,66,79,80,85,91,99
Ensemble 7 (8.8)52,53,62,76,78,81,95
Nearest neighbors 6 (7.5)35,50,54,72,98,103
Gaussian process 5 (6.3)5,29,31,55,98
Clustering 5 (6.3)51,61,87,89,92
Reinforcement learning 4 (5)34,63,73,77
Generalized additive models 3 (3.8)76,90,95
Bagging 3 (3.8)35,50,76
Discriminant analysis 2 (2.5)35,61
Word vectorization 2 (2.5)64,89
Other methodsd 10 (12.5)32,35,37,44,54,58,72,74–76
Sample size Qualitative 10-19 clinicians
Model development 127 patients to 296,724 hospital admissions
Clinical specialtya Intensive care (adult) 37 (46.3)5,12,28,30,34,43,44,51–53,55,56,58–61,63,64,66–69,71–77,79,80,83,86,87,89,91,101
In-hospital, acute care/not further specified 14 (17.5)30,31,34,46,50,54,69,82,85,90,97,103–105
Emergency medicine 14 (17.5 )12,35,36,40,42,57,69,84,86,88,90,93,95,99
Cardiology 7 (8.8)37,71,81,86,88,92,102
Pediatric (acute and intensive care) 6 (7.5)32,58,70,78,81,100
Nephrology 5 (6.3)62,66,75,79,83
Neonatal intensive care 4 (5)33,94,96,98
Stroke 4 (5)47–49,86
Surgery 3 (3.8)38,41,86
Diabetes 2 (2.5)39,65
Pulmonology/respiratory 2 (2.5)42,90
Nursing 1 (1.3)45
Trauma 1 (1.3)95
In-hospital, specifically: emergency medicine, intensive care, cardiothoracic surgery/transplant, neurology/vascular/stroke, gastrointestinal, oncology/hematology/immunology/pharmacology 1 (1.3)86

Values are n (%) or range.

a

Studies may fall into more than 1 category.

b

Does not meet our definition of machine learning but included for purposes of reporting all methods authors compared.

c

Including LASSO, Ridge, and Elastic Net.

d

Generalized linear models, conditional inference recursive partition, conditional random fields, Weibull-Cox proportional hazards, lazy learner, piecewise-constant conditional intensity model, analysis of covariance (see footnote b), analysis of variance (see footnote b), fuzzy modeling (see footnote b), switching-state autoregressive model, mimic learning, nearest shrunken centroids, J48 algorithm, PART rule.